Patents
Patents for C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
05/2009
05/07/2009US20090114596 Nanofilm and membrane compositions
04/2009
04/16/2009US20090098047 Bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands
03/2009
03/24/2009CA2224060C Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
03/12/2009US20090068248 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
12/2008
12/25/2008US20080318917 Polyethylene glycolated superoxide dismutase mimetics
12/23/2008US7468435 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
12/02/2008US7459551 Method for preparing cyclic compounds
11/2008
11/27/2008US20080290034 Bridged macrocyclic module compositions
10/2008
10/23/2008US20080262222 Near infrared dyes
10/15/2008CN100425610C Method for preparing phthalocyanines
10/07/2008US7432371 Nanofilm and membrane compositions
09/2008
09/04/2008US20080213780 Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
08/2008
08/05/2008US7407645 Contast agents;magn
07/2008
07/31/2008WO2008092120A1 Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
05/2008
05/06/2008US7368100 Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same
04/2008
04/17/2008US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
02/2008
02/20/2008EP1289968B1 Cyclic urea compounds and preparation thereof
02/19/2008US7332149 Diagnosis, therapy of cancer, rheumatoid arthritis, for monitoring therapeutic angiogenesis treatment and destruction of new angiogenic vasculature, imaging tumors, atherosclerosis, restenosis, cardiac ischemia, and myocardial reperfusion injury
01/2008
01/22/2008US7321045 Vitronectin receptor antagonist pharmaceuticals
01/09/2008CN100360534C Separation of regioisomers of metal phthalocyanines
10/2007
10/30/2007CA2288703C Phthalocyanine and use of phthalocyanine as a marking agent
08/2007
08/29/2007EP1824856A1 2,4 (4,6) pyrimidine derivatives
08/28/2007CA2072934C Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
05/2007
05/30/2007CN1318516C Process for preparation of substituted amido phthalocyanine derivatives and substituted amido phthlocyanine derivatives
04/2007
04/05/2007US20070078258 Purification process
04/04/2007CN1939919A Low-toxic and broad-spectrum phthalocyanine bactericide, its production and use
03/2007
03/06/2007US7186828 Cyclic urea compounds and preparation thereof
03/06/2007US7186739 O-succinimidyl-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]-ethylcarbamate's used as monomers active in the synthesis of di- and tri-substituted ureas and urea oligomers
01/2007
01/24/2007CN1902205A Method for preparing phthalocyanines
12/2006
12/19/2006US7151096 For therapy and prophylaxis of diseases and disorders associated with cyclin-dependent kinases (CDKs) activity
12/12/2006US7148346 Feeding the feedstock into an extraction column under conditions adapted for separating more- or less-polar impurities from feedstock, lighter phase flows counter to a heavier phase; product is a cyclosporin, a rapamycin
11/2006
11/30/2006US20060270846 Synthons; nanomembranes
11/07/2006US7132513 Bifunctional chelating agent
10/2006
10/25/2006CN1850808A Non oxaza organics and their use
09/2006
09/06/2006CN1273448C Method for preparing aryl alkyl hydrogen peroxide
08/2006
08/23/2006CN1823038A Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
08/15/2006US7091338 An ion-containing compound is admixed with macromolecular crown ether or derivatives to form an extractant/ion complex, and the predetermined extractant/ion complex is separated from the diluent by using the new phase affinity
08/09/2006EP1688417A2 Phthalocyanine compounds and use thereof in inks for ink jet printing, methods for generating patterns
08/09/2006CN1816552A Method for producing alkoxy-substituted phthalocyanins
07/2006
07/05/2006CN1796386A New antifungal compound preparation method and application
06/2006
06/15/2006WO2006061415A1 2,4 (4,6) pyrimidine derivatives
06/15/2006US20060128680 porosity; nanostructure
06/15/2006CA2588761A1 2,4(4,6)pyrimidine derivatives
06/13/2006US7060845 Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
06/13/2006US7060290 Phosphocholine linked prodrug derivatives
06/07/2006CN1258527C Method for preparing aryl alkyl hydrogen peroxide
05/2006
05/16/2006US7045606 Chelate compound containing ligand with steroids, enzymes, hapten and antibodies
03/2006
03/29/2006EP1640368A2 Cyclic ureas and processes for their preparation
03/29/2006CN1247587C Tert. alkylphenoxy substituted polycyclic compounds
03/14/2006US7012140 substituted tetraazacyclododecane ligand containing a macrocyclic ring and a paramagnetic lanthanide metal ion coordinated to the tetraazacyclod odecane ligand; coordinated geometry adjusts the water exchange rate of the contrast agent
03/07/2006US7008613 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis
02/2006
02/07/2006US6995247 Ac-HEHA and related compounds, methods of synthesis and methods of use
12/2005
12/08/2005WO2004078682A3 Cyclic compounds and compositions as protein kinase inhibitors
11/2005
11/02/2005CN1225461C Preparation method of 1, 4, 7, 10, 13-penta azacyclopentadecane
09/2005
09/20/2005CA2125978C Improvements in chemical compounds
07/2005
07/27/2005CN1646501A Nanofilm and membrane compositions
07/27/2005CN1646116A Macrocyclic module compositions
07/21/2005US20050159585 Forming acyl azide function on acid group of amino acid derivative, then transforming to isocyanate
07/21/2005US20050159584 O-succinimidyl-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]-ethylcarbamate's used as monomers active in the synthesis of di- and tri-substituted ureas and urea oligomers
07/21/2005CA2550869A1 Process for the preparation of phthalocyanines
07/07/2005US20050148566 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
06/2005
06/29/2005EP1481268A4 Nanofilm and membrane compositions
06/29/2005EP1480635A4 Macrocyclic module compositions
06/28/2005US6911457 Diabetes imaging probes
05/2005
05/11/2005CN1615303A Improved purification of 4, 4'(5')-di-t-butylcyclohexano-18-crown-6
04/2005
04/07/2005US20050072736 Purification process
04/06/2005CN1195733C Method for preparation of aryl alkyl hydrogen peroxide
02/2005
02/23/2005EP1507526A2 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
02/09/2005EP1453813A4 IMPROVED PURIFICATION OF 4, 4'(5')-DI- i t /i -BUTYLCYCLOHEXANO-18-CROWN-6
02/09/2005CN1188397C Process for preparation of acid chloride compounds
12/2004
12/23/2004US20040260085 Oriented amphiphilic molecules and macrocyclic modules from organic synthons R,R-1,2-transdiaminocyclohexane and 4-substituted 2,6-diformyl phenol; dialysis membranes with improved sodium, potassium and chloride ion permselectivity in water
12/02/2004US20040242852 Bifunctional chelating agent for actinium
12/01/2004EP1481268A2 Nanofilm and membrane compositions
12/01/2004EP1480635A2 Macrocyclic module compositions
11/2004
11/25/2004US20040235841 For therapy and prophylaxis of diseases and disorders associated with cyclin-dependent kinases (CDKs) activity
11/25/2004CA2525447A1 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
10/2004
10/21/2004US20040208822 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis
10/06/2004EP1144414B1 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
09/2004
09/23/2004US20040184991 Ac-HEHA and related compounds, methods of synthesis and methods of use
09/16/2004WO2004078682A2 Cyclic compounds and compositions as protein kinase inhibitors
09/16/2004WO2003095398A3 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
09/15/2004EP1185526B1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use
09/08/2004EP1453813A2 IMPROVED PURIFICATION OF 4, 4'(5')-DI- i t /i -BUTYLCYCLOHEXANO-18-CROWN-6
08/2004
08/18/2004EP0619813B1 Linked cyclic polyamines with activity against hiv
07/2004
07/21/2004EP1438299A1 Bifunctional chelating agent for actinium
07/08/2004US20040131550 Bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands
07/06/2004US6759406 Quaternary ammonium compounds
05/2004
05/05/2004CN1493566A Preparation method of 1,4,7,10,13-penta azacyclopentadecane
04/2004
04/15/2004WO2003067286A3 Nanofilm and membrane compositions
03/2004
03/25/2004US20040057904 Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands
03/18/2004WO2003086563A3 Diabetes imaging probes
03/18/2004US20040050782 Solvent extraction to separate impurities; countercurrent fluid flow
03/04/2004US20040044199 Cyclic urea compounds and preparation thereof
02/2004
02/25/2004EP1073629B1 Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such a compound or membrane
02/24/2004US6696551 225Ac-HEHA and related compounds, methods of synthesis and methods of use
02/19/2004US20040034223 3-24 synthons independently selected from aryl, heteroaryl, alicyclic and heteroalicyclic, provided at least one of the synthon is different from other, and these synthons are bonded through linkers, thus forming a closed ring of synthon
02/12/2004WO2003066646A3 Macrocyclic module compositions
02/11/2004EP0755385B1 Chelant compounds
12/2003
12/16/2003CA2178272C Antiviral monocyclic polyamines
11/2003
11/20/2003WO2003095398A2 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
1 2 3 4 5